Proteomics

Dataset Information

0

Comparative proteomics identifies different metabolic pathways activated by p53 mutants G245S and R337H associated with Li-Fraumeni syndrome


ABSTRACT: Li-Fraumeni syndrome (LFS) is a hereditary cancer predisposition disorder associated with germline mutations in the TP53 tumor suppressor gene. The p53 mutation spectrum associated with LFS is similar to that found in somatic tumors, with most of them, such as the G245S mutation, occurring in the DNA-binding domain of protein. However, in Brazil the most frequent p53 mutation associated with LFS, R337H, affects the oligomerization domain of p53. The goal of this study is to characterize the molecular pathways activated by p53 mutants G245S and R337H in cancer cells. The p53-null NCI-H1299 cell line was stably transfected with pCMV-Neo-Bam vectors to drive expression of the G245S and R337H p53 mutants and nuclear localization of mutant p53s was verified by western blot and immunocytochemistry. The molecular pathways activated by mutant p53s were characterized by cellular proteomics using DIA-based mass spectrometry. Cell assays confirmed the functional enrichment of oxidative phosphorylation and mitochondrial ATP synthesis proteins in cells expressing R337H p53 that may account for the increased aerobic respiration levels and higher mitochondrial activity. In contrast, glycolysis and angiogenesis were pathways upregulated in cells expressing G245S p53 which could be related to glucose- and L-glutamine-dependent proliferation, decreased aerobic respiration and higher capacity to form spheroids.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Richard Wilson  

LAB HEAD: Dr Richard Wilson

PROVIDER: PXD025056 | Pride | 2026-06-29

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
20200907_BR_GS1.raw Raw
20200907_BR_GS2.raw Raw
20200907_BR_GS3.raw Raw
20200907_BR_NULL_1.raw Raw
20200907_BR_NULL_2.raw Raw
Items per page:
1 - 5 of 10
altmetric image

Publications

p53 mutants G245S and R337H associated with the Li-Fraumeni syndrome regulate distinct metabolic pathways.

Meneghetti Bruna Valandro BV   Wilson Richard R   Dias Camila Kehl CK   Cadore Nathan Araujo NA   Klamt Fábio F   Zaha Arnaldo A   Ferreira Henrique Bunselmeyer HB   Monteiro Karina Mariante KM  

Biochimie 20220401


Li-Fraumeni and Li-Fraumeni-like syndromes (LFS/LFL) are hereditary cancer predisposition disorders associated with germline mutations in the TP53 tumor suppressor gene. Here, we stably expressed LFS/LFL-associated p53 mutants R337H and G245S in p53-null H1299 cells to study their cellular and molecular effects. Mutant proteins showed distinct oligomerization states and opposing effects on cell proliferation and viability. Stable expression of p53<sup>G245S</sup> enhanced cell proliferation and  ...[more]

Similar Datasets

2010-10-01 | E-GEOD-22355 | biostudies-arrayexpress
2010-10-01 | GSE22355 | GEO
2024-01-03 | GSE248138 | GEO
2024-01-03 | GSE248137 | GEO
2025-03-23 | GSE290495 | GEO
2010-06-19 | E-GEOD-15657 | biostudies-arrayexpress
2024-08-01 | GSE182565 | GEO
2010-01-01 | GSE18432 | GEO
2022-03-23 | GSE198802 | GEO
| PRJNA1425579 | ENA